INVESTOR RELATIONS

FINANCIAL NEWS (PRESS RELEASES)

FINANCIAL NEWS (PRESS RELEASES)

There are currently no events to display.
Date Title
08/17/18
Summary ToggleViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock

CLEVELAND , Aug. 17, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the completion of its previously announced underwritten public offering of

Printer Friendly Version
08/14/18
Summary ToggleViewRay Announces Pricing of Public Offering of Common Stock

CLEVELAND , Aug. 14, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten public offering of 16,216,217 shares of common

Printer Friendly Version
08/14/18
Summary ToggleViewRay Announces Proposed Public Offering of Common Stock

CLEVELAND , Aug. 14, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced that it has commenced an underwritten public offering of $125.0 million of shares

Printer Friendly Version
08/03/18
Summary ToggleViewRay Reports Second Quarter 2018 Financial Results

CLEVELAND , Aug. 3, 2018 /PRNewswire/ --   ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2018 . Second Quarter 2018 Highlights: Total revenue of $16.4 million, primarily from 3 revenue units, up from $0.7 million in 2Q 2017.

Printer Friendly Version
07/31/18
Summary ToggleViewRay Announces Conference Call and Webcast of Second Quarter 2018 Financial Results to be Held Before Market on August 3, 2018

CLEVELAND , July 31, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2018 financial results, which will take place on Friday, August 3, 2018 before market. ViewRay will hold a conference call on Friday August 3, 2018 at 8:30

Printer Friendly Version
07/26/18
Summary ToggleLeading Medical Physics Meeting to Feature More than 50 Presentations on ViewRay's MRIdian MRI-Guided Radiotherapy

Presentations Highlight MRIdian Clinical Experience with On-Table Adaptive Therapy Combined with the Novel Ability to Visualize and Actively Target Tumors that Move CLEVELAND , July 26, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), makers of the world's only FDA -cleared MRI-guided radiation

Printer Friendly Version
07/24/18
Summary ToggleViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors

New Officers and Directors Bring Extensive Medical Company Growth Experience to ViewRay ViewRay Pre-Releases Preliminary Second Quarter 2018 Revenue of $16 Million and Reaffirms Revenue Guidance of $80 to $90 Million for 2018 CLEVELAND , July 24, 2018 /PRNewswire/ --  ViewRay, Inc.

Printer Friendly Version
07/11/18
Summary ToggleViewRay's MRIdian Linac Awarded French Tender for MR Image-guided Radiation Therapy

UNICANCER to Bring Next Generation Radiotherapy to Centre Georges-François Leclerc (CGFL) CLEVELAND , July 11, 2018   /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced that the company's MRIdian® Linac has been selected for installation at Centre Georges-François Leclerc (CGFL) in Dijon,

Printer Friendly Version
07/09/18
Summary ToggleLoyola Medicine/Palos Health Installs ViewRay's MRIdian Linac System for MR Image-Guided Radiation Therapy

Chicago-Area Provider Becomes First Community Hospital in the U.S. with ViewRay's Next Generation Linear Accelerator-Based System CLEVELAND , July 9, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Palos Health , in partnership with Loyola Medicine, has installed ViewRay's

Printer Friendly Version
06/21/18
Summary ToggleUniversity of Wisconsin Begins Patient Treatments with ViewRay's MRIdian Linac

Becomes the First Hospital to Upgrade Previous Generation MRIdian to Advanced Linear Accelerator-based System CLEVELAND , June 21, 2018 /PRNewswire/   -- ViewRay, Inc. (Nasdaq: VRAY) announced today that University of Wisconsin Carbone Cancer Center in Madison, Wisconsin , has begun patient

Printer Friendly Version
06/13/18
Summary TogglePioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System

Next Generation Cancer Therapy Enables Delivery of Higher, Potentially More Effective Radiation Dose Regimens CLEVELAND , June 13, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Printer Friendly Version
06/04/18
Summary ToggleViewRay® to Present at the Jefferies 2018 Global Healthcare Conference

CLEVELAND , June 4, 2018 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) announced today that James F. Dempsey , PhD, Founder and Chief Scientific Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to present at the Jefferies 2018 Global Healthcare Conference in New York, NY .

Printer Friendly Version
05/23/18
Summary ToggleWorld-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy Symposium

Educational Event Aims to Share Clinical Expertise and Best Practices in MR Image-guided Radiation Therapy CLEVELAND , May 23, 2018 /PRNewswire/ -- Experts in MR image-guided radiation therapy will share their experiences during an educational symposium to be held on Friday, September 28, 2018 in

Printer Friendly Version
05/16/18
Summary ToggleViewRay to Present at the UBS Global Healthcare Conference

CLEVELAND , May 16, 2018 /PRNewswire/ -- ViewRay ® , Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to present at the UBS Global Healthcare Conference in New York, NY . Event :                 UBS Global

Printer Friendly Version
05/10/18
Summary ToggleViewRay Reports First Quarter 2018 Financial Results

Reiterates 2018 Financial Guidance CLEVELAND , May 10, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2018 . First Quarter 2018 Highlights: Total revenue of $26.2 million, primarily from 4 revenue units, up from $1.2

Printer Friendly Version
05/07/18
Summary ToggleViewRay Announces Conference Call and Webcast of First Quarter 2018 Financial Results to be Held After Market on May 10, 2018

CLEVELAND , May 7, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2018 financial results, which will take place on Thursday, May 10, 2018 after market. ViewRay will hold a conference call on Thursday, May 10, 2018 at 4:30 p.m.

Printer Friendly Version
05/02/18
Summary ToggleViewRay's Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development for MRIdian MR-Image Guided Radiotherapy MRIdian On-Table Adaptive Therapy a Focal Point at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting CLEVELAND , May 2, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that members of its Clinical Cooperative Think Tank (C2T2) gathered last week in Printer Friendly Version
04/30/18
Summary ToggleMiami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients with ViewRay's MRIdian® Linac

Novel MR Image-Guided Radiotherapy Enables High-Definition Tumor Visualization and On-table Adaptive Cancer Treatment CLEVELAND , April 30, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Miami Cancer Institute at Baptist Health South Florida has begun patient treatments

Printer Friendly Version
04/19/18
Summary ToggleVU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR Image-Guided Radiotherapy Treatment on ViewRay MRIdian® Linac

Two Prestigious Centers in Europe Start Treating Patients with MRIdian® Linac CLEVELAND , April 19, 2018   /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that VU University Medical Center (VUmc) in Amsterdam has begun patient treatments using the Company's next generation system,

Printer Friendly Version
04/18/18
Summary ToggleViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy

New MR Pulse Sequences and Imaging Enhancements Expected to Provide Cutting-Edge Tumor and Healthy Tissue Visualization* CLEVELAND , April 18, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today new MR imaging technologies under development for its MRIdian ® Linac radiotherapy system.

Printer Friendly Version
04/04/18
Summary ToggleUniversity Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided Radiotherapy Linac

MR-Image Guided Linac Treatments in Europe to Commence by Mid-April CLEVELAND , April 4, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the University Clinic Heidelberg in Germany has completed installation and commissioning of the hospital's new MRIdian Linac, the

Printer Friendly Version
03/27/18
Summary ToggleViewRay Surpasses 50th Order for MRIdian® System for Precision Cancer Treatment

Milestone Demonstrates Rapid Adoption of Next-Generation MR-Image Guided Radiation Therapy CLEVELAND , March 27, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced that the company surpassed its 50 th MRIdian MR image-guided radiation therapy system order during the first quarter of 2018 -

Printer Friendly Version
03/16/18
Summary ToggleNearly 200 Oncology Experts Gather to Discuss Advanced Applications of MR Image-Guided Radiotherapy Educational Event Featured Presentations from Five MRIdian® Users Highlighting MR Image-guided Radiation Therapy Clinical Experience and Best Practices CLEVELAND , March 16, 2018 /PRNewswire/ -- Experts in MR image-guided radiation therapy convened today to discuss MR image-guided radiation therapy Printer Friendly Version
03/15/18
Summary ToggleViewRay's MRIdian MR Image-Guided Radiotherapy Linac Receives Japanese Regulatory Approval (Shonin) Clearance Expected to Accelerate Market Adoption of Next-Generation Cancer Care CLEVELAND , March 15, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the MRIdian Printer Friendly Version
03/14/18
Summary ToggleViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital Zurich Oncologists at Leading Swiss Hospital Select MRIdian Linac as Preferred Technology In Competitive European Tender CLEVELAND , March 14, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today an order for the company's MRIdian® MR image-guided linac at the University Hospital Zurich Printer Friendly Version
03/12/18
Summary ToggleViewRay Reports Fourth Quarter and Full Year 2017 Financial Results Achieved Record Levels of Revenue, Gross Orders and Backlog for Fourth Quarter and Full Year Introduces 2018 Revenue Guidance of $80-$90 Million CLEVELAND , March 12, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended Printer Friendly Version
03/06/18
Summary ToggleViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2017 Financial Results to be Held on March 12, 2018 CLEVELAND , March 6, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2017 financial results, which will take place on Monday, March 12, 2018 before market open. ViewRay will hold a conference call on Monday, Printer Friendly Version
02/27/18
Summary ToggleViewRay® to Participate in Upcoming Conferences CLEVELAND , Feb. 27, 2018 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to participate in two upcoming investor conferences. The first conference is the 2018 BTIG Healthcare Printer Friendly Version
02/26/18
Summary ToggleViewRay Announces $59 Million Equity Financing Financing to Further Support Growth of MRIdian Linac CLEVELAND , Feb. 26, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), makers of the world's first and only clinical MRI-guided radiation therapy system, announced today that it has entered into an agreement to sell its common stock and Printer Friendly Version
02/07/18
Summary ToggleViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors New Directors Bring Extensive Medical Device Experience to the Board CLEVELAND , Feb. 7, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided radiation therapy system, announced today the appointment of medical device industry veterans Scott Printer Friendly Version
01/08/18
Summary ToggleViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results CLEVELAND , Jan. 8, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2017 . The preliminary results reported have not been audited and are subject to change. Printer Friendly Version
12/19/17
Summary ToggleOncology Experts to Convene for Symposium to Advance MR Image-Guided Radiation Therapy Educational Event Aimed at Sharing Clinical Knowledge and Best Practices for Establishing an MR Image-guided Radiation Therapy Program CLEVELAND , Dec. 19, 2017 /PRNewswire/ -- Experts in MR image-guided radiation therapy will share their experiences during a global symposium to be held on Friday, Printer Friendly Version
11/21/17
Summary ToggleViewRay® to Participate in Upcoming Conferences CLEVELAND , Nov. 21, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer are scheduled to participate in two upcoming investor conferences. The first conference is the 29th Annual Piper Jaffray Printer Friendly Version
11/13/17
Summary ToggleViewRay Reports Third Quarter 2017 Financial Results Strong Order Momentum in Q3, continuing in Q4 CLEVELAND , Nov. 13, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the third quarter and nine months ended September 30, 2017 . Third Quarter & Recent Financial Highlights: Total revenue of $12.2 million in Q3 Printer Friendly Version
11/10/17
Summary ToggleWashington University Completes Installation of Second MRIdian MR-Guided Radiotherapy System from ViewRay Greater Assurance in Tumor Targeting Drives Expansion of MR-Guided Radiation Therapy Program CLEVELAND , Nov. 10, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Printer Friendly Version
11/09/17
Summary ToggleViewRay® to Present at the Stifel 2017 Healthcare Conference CLEVELAND , Nov. 9, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY ) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer are scheduled to present at the Stifel 2017 Healthcare Conference. Event:           Stifel 2017 Healthcare Conference Date:  Printer Friendly Version
11/08/17
Summary ToggleViewRay Announces Conference Call and Webcast of Third Quarter 2017 Financial Results to be Held on November 13, 2017 CLEVELAND , Nov. 8, 2017 /PRNewswire/ --   ViewRay, Inc. (Nasdaq:  VRAY ) announced today details relating to the release of its third quarter 2017 financial results, which will take place on Monday, November 13, 2017 before market open. ViewRay will hold a conference call on Monday, November 13, Printer Friendly Version
11/03/17
Summary ToggleViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender Top Cancer Centers to Bring Benefits of MR-Guided Soft-tissue Visualization and Adaptive Treatment Delivery to Copenhagen CLEVELAND , Nov. 3, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian® Linac has been selected for installation at Rigshospitalet and Printer Friendly Version
10/24/17
Summary ToggleViewRay Raises $50 Million through Sale of Common Stock Financing to Support Ongoing Commercialization of MRIdian Linac CLEVELAND , Oct. 24, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided radiation therapy system, announced today that it has raised aggregate gross proceeds of approximately $50 Printer Friendly Version
10/17/17
Summary ToggleEarly Clinical Data Suggests Nearly 2X Prolonged Median Survival for Inoperable, Locally Advanced Pancreatic Cancer with MRIdian MR-Guided Radiation Therapy Study Indicates Higher Dosing Enabled by MR-guidance Combined with Daily On-table Adaptation Led to Significant Potential Clinical Benefits for Pancreatic Cancer Patients CLEVELAND , Oct. 17, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), maker of the world's first and only clinical MRI-guided Printer Friendly Version
09/25/17
Summary ToggleViewRay Launches Clinical Trial Following Compelling Early Pancreatic Cancer Data with MRIdian System First Initiative Based on Retrospective Study That Suggests Potential for Significantly Prolonged Survival CLEVELAND , Sept. 25, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today the launch of a multi-center prospective clinical trial for locally advanced unresectable pancreatic Printer Friendly Version
09/21/17
Summary ToggleViewRay MRIdian to be Featured in 21 Presentations from Seven Leading Centers at ASTRO ViewRay to Host Inaugural Clinical Cooperative Think Tank Meeting to Advance MR-Guided Radiation Therapy Research CLEVELAND , Sept. 21, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the company's MRIdian and MRIdian Linac systems will be featured at the Annual Meeting of Printer Friendly Version
09/20/17
Summary ToggleViewRay® to Host Analyst & Investor Meeting at ASTRO in San Diego CLEVELAND , Sept. 20, 2017 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for analysts and investors on Monday, September 25, 2017 , during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego . Printer Friendly Version
09/06/17
Summary ToggleViewRay® to Participate in Morgan Stanley Global Healthcare Conference CLEVELAND , Sept. 6, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer are scheduled to participate at the Morgan Stanley Global Healthcare Conference in New York, NY . Printer Friendly Version
08/07/17
Summary ToggleViewRay Reports Second Quarter 2017 Financial Results On Track to Achieve 2017 Financial Guidance CLEVELAND , Aug. 7, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter and six months ended June 30, 2017 . Second Quarter 2017 Highlights: Received record quarterly new orders for MRIdian Linac Printer Friendly Version
08/03/17
Summary ToggleEarly Clinical Experience with ViewRay's MRIdian Linac Presented at Leading Medical Physics Meeting AAPM Talks Highlight Clinical Value of MRIdian On-Table Adaptive Therapy for Escalating Target Dose and Avoiding Nearby Organs at Risk CLEVELAND , Aug. 3, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today highlights from the 2017 Annual Meeting of the American Association of Printer Friendly Version
08/01/17
Summary ToggleViewRay Announces Conference Call and Webcast of Second Quarter 2017 Financial Results to be Held on August 7, 2017 CLEVELAND , Aug. 1, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2017 financial results, which will take place on Monday, August 7, 2017 after market close. ViewRay will hold a conference call on Monday, August 7, 2017 at Printer Friendly Version
07/21/17
Summary ToggleLeading Medical Physics Meeting to Feature First Presentations on Clinical Experience with ViewRay's MRIdian Linac 30 Presentations Highlight MRIdian's Growing Role in Cancer Care CLEVELAND , July 21, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY), makers of the world's only FDA -cleared MRI-guided radiation therapy system with linear accelerator-based delivery, announced today that the company's MRIdian® Printer Friendly Version
07/20/17
Summary ToggleFirst Patients Treated with ViewRay's MRIdian Linac System at Henry Ford Health System World's First FDA-Cleared MRI-guided Linear Accelerator-based Radiation Therapy System Now Treating Patients CLEVELAND , July 20, 2017 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that the first cancer patients have been treated using the company's MRIdian Linac system at Henry Printer Friendly Version
06/26/17
Summary ToggleNational Cancer Center Japan Treats First Patients Using ViewRay MRIdian System Printer Friendly Version
06/13/17
Summary ToggleViewRay® to Present at The JMP Securities Life Sciences Conference Printer Friendly Version
05/30/17
Summary ToggleViewRay® to Present at Citi's 2017 Small & Mid Cap Conference Printer Friendly Version
05/15/17
Summary ToggleViewRay Reports First Quarter 2017 Financial Results Printer Friendly Version
05/15/17
Summary ToggleCompelling Early Pancreatic Cancer Data with ViewRay's MRIdian System Presented at ESTRO 36 Printer Friendly Version
05/10/17
Summary ToggleViewRay Announces Conference Call and Webcast of First Quarter 2017 Printer Friendly Version
05/02/17
Summary ToggleViewRay Showcases World's First Commercially Available MRI-Guided Linac System at Leading European Radiation Oncology Meeting Printer Friendly Version
04/13/17
Summary ToggleViewRay Announces $15.0 Million Capacity Expansion of its Term Loan Agreement Printer Friendly Version
03/16/17
Summary ToggleViewRay Reports Fourth Quarter and Full Year 2016 Financial Results Printer Friendly Version
03/14/17
Summary ToggleViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2016 Financial Results to be Held on March 16, 2017 Printer Friendly Version
02/27/17
Summary ToggleViewRay Receives FDA 510(k) Clearance for MRIdian Linac Printer Friendly Version
02/22/17
Summary ToggleViewRay® to Participate in Upcoming Conferences Printer Friendly Version
01/24/17
Summary TogglePrivate Japanese Hospital Purchases ViewRay MRIdian System Printer Friendly Version
01/19/17
Summary ToggleGerman Research Foundation (DFG) Purchases ViewRay MRIdian Linac for University Clinic Heidelberg Printer Friendly Version
01/18/17
Summary ToggleViewRay Raises $26.1 Million in Private Placement Printer Friendly Version
11/30/16
Summary TogglePublished Study Highlights MRIdian System's Value in Sparing Healthy Tissue from Radiation Printer Friendly Version
11/14/16
Summary ToggleViewRay Reports Third Quarter 2016 Financial Results Printer Friendly Version
11/07/16
Summary ToggleViewRay to Present at the Stifel 2016 Healthcare Conference Printer Friendly Version
11/07/16
Summary ToggleViewRay Announces Conference Call and Webcast of Third Quarter 2016 Financial Results to be Held on November 14, 2016 Printer Friendly Version
10/13/16
Summary ToggleMRIdian Clinical Outcomes Data and Adaptive Capabilities: Highlights from ASTRO 2016 Printer Friendly Version
09/22/16
Summary ToggleViewRay MRIdian Clinical Experience to be highlighted by Five Leading Centers at Largest Radiation Oncology Meeting Printer Friendly Version
09/21/16
Summary ToggleNational Cancer Center Japan Purchases ViewRay MRIdian System Printer Friendly Version
09/19/16
Summary ToggleViewRay Receives CE Mark Approval for its MRIdian Linac System Printer Friendly Version
09/09/16
Summary ToggleViewRay Receives Chinese Regulatory Approval for its MRIdian System Printer Friendly Version
09/06/16
Summary ToggleViewRay to Present at the 18th Annual Rodman & Renshaw Global Investment Conference Printer Friendly Version
09/01/16
Summary ToggleHenry Ford to Acquire ViewRay MRIdian Linac Research System Printer Friendly Version
08/19/16
Summary ToggleViewRay Announces $13.75 Million Private Placement Printer Friendly Version
08/15/16
Summary ToggleViewRay Reports Second Quarter 2016 Financial Results Printer Friendly Version
08/15/16
Summary ToggleViewRay's MRIdian System Receives Japanese Regulatory Approval (Shonin) Printer Friendly Version
08/08/16
Summary ToggleFirst Scientific Presentations on ViewRay's MRIdian Linac Technology Printer Friendly Version
08/04/16
Summary ToggleViewRay Announces Conference Call and Webcast of Second Quarter 2016 Printer Friendly Version
07/28/16
Summary ToggleLeading Medical Physics Meeting to Feature 40 Presentations on ViewRay's MRIdian System Printer Friendly Version
06/27/16
Summary ToggleViewRay® Added to Russell 3000, Russell Global and Russell Microcap Indexes Printer Friendly Version
06/09/16
Summary ToggleViewRay® Appoints Ajay Bansal as Chief Financial Officer Printer Friendly Version
05/13/16
Summary ToggleViewRay Reports First Quarter 2016 Financial Results Printer Friendly Version
05/09/16
Summary ToggleRadiosurgery Society® Webinar Features UCLA Doctors Discussing Clinical Experience with ViewRay's MRIdian System Printer Friendly Version
05/06/16
Summary ToggleViewRay Announces Conference Call and Webcast of First Quarter 2016 Financial Results to be Held on May 13, 2016 Printer Friendly Version
04/28/16
Summary ToggleViewRay's MRI-Guided Radiation Therapy System to be featured at Leading European Radiation Oncology Meeting Printer Friendly Version
04/18/16
Summary ToggleTreatment with ViewRay's MRI-Guided Radiation Therapy Now Available on the U.S. East Coast Printer Friendly Version
04/12/16
Summary ToggleViewRay® Appoints Dr. Henry A. McKinnell, Jr. to its Board of Directors Printer Friendly Version
03/28/16
Summary ToggleViewRay Reports Fourth Quarter and Full Year 2015 Financial Results and Up-listing to the NASDAQ Global Market Printer Friendly Version
03/24/16
Summary ToggleViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2015 Financial Results to be Held on March 28, 2016 Printer Friendly Version
03/24/16
Summary ToggleFirst MRIdian System Installed in Europe at VU University Medical Center of Amsterdam Printer Friendly Version
03/14/16
Summary ToggleWashington University Acquires ViewRay Research System to Investigate MRI-Guided Linac Capabilities Printer Friendly Version
03/08/16
Summary ToggleViewRay to Present at the 28th Annual ROTH Conference Printer Friendly Version
03/02/16
Summary ToggleViewRay to Present at the 36th Annual Cowen Health Care Conference Printer Friendly Version
02/19/16
Summary ToggleFox Business Network Varney & Co. Interview with ViewRay CEO Chris Raanes Printer Friendly Version
01/11/16
Summary ToggleWorld's First MRIdian Center Celebrates Two Years of MRI-Guided Radiation Treatments Printer Friendly Version
12/29/15
Summary ToggleViewRay® Appoints Brian K. Roberts to its Board of Directors Printer Friendly Version
12/16/15
Summary ToggleViewRay CEO interviewed on Stock News Now Printer Friendly Version
11/24/15
Summary ToggleViewRay® to Present at the LD Micro “Main Event” Microcap Conference Printer Friendly Version
11/12/15
Summary ToggleViewRay® to Present at the Stifel 2015 Healthcare Conference Printer Friendly Version
11/09/15
Summary ToggleViewRay Reports Third Quarter 2015 Financial Results Printer Friendly Version
10/18/15
Summary ToggleViewRay® Receives Regulatory Approval to Sell MRI-Guided Radiation Therapy System in Korea Printer Friendly Version
10/15/15
Summary ToggleMRIdian® Clinical Experience and Faster, Higher-Resolution Imaging to be featured at Largest Radiation Oncology Meeting Printer Friendly Version
10/13/15
Summary ToggleViewRay® Receives 2015 Frost & Sullivan Technology Innovation Leadership Award Printer Friendly Version
09/15/15
Summary ToggleViewRay® Announces First International MRIdian® Installation at Seoul National University Hospital Printer Friendly Version
09/02/15
Summary ToggleRadiosurgery Society® Webinar on MR-Guided Stereotactic Body Radiation Therapy Yields Record Attendance Printer Friendly Version
08/19/15
Summary ToggleViewRay® (VRAY) Completes Private Placement, Raises Aggregate of $29.4 Million Printer Friendly Version
07/23/15
Summary ToggleViewRay Completes Alternative Public Offering, Raises $26.7 Million Printer Friendly Version
07/09/15
Summary ToggleViewRay's MRIdian System to be featured at Leading Medical Physics Meeting Printer Friendly Version
06/30/15
Summary ToggleViewRay Secures Up To $50M in Debt Financing From CRG Printer Friendly Version
04/23/15
Summary ToggleViewRay to Showcase World's Only Commercially Available MRI-Guided Radiation Therapy System at Leading European Radiation Oncology Meeting Printer Friendly Version
02/03/15
Summary ToggleViewRay Receives First European Order for its MRIdian System Printer Friendly Version
01/22/15
Summary ToggleItochu Named the Exclusive Distributor for Viewray's MRI-Guided Radiation Therapy System in Japan Printer Friendly Version
11/11/14
Summary ToggleViewRay MRIdian System Receives CE Mark Printer Friendly Version
09/12/14
Summary ToggleViewRay to Showcase World’s Only MRI-Guided Radiation Therapy System In Clinical Use at Largest Radiation Oncology Meeting Printer Friendly Version
09/10/14
Summary ToggleUniversity of Wisconsin Carbone Cancer Center Becomes First in the World to Treat Patients with MRIdian’s Soft-Tissue-Tracking-Beam Control Printer Friendly Version
09/09/14
Summary ToggleViewRay’s MRIdian Makes Adaptive Radiation Therapy a Clinical Reality Printer Friendly Version
07/31/14
Summary ToggleRevolutionary Radiation Therapy System from ViewRay is Acquired by Sylvester Comprehensive Cancer Center at the University of Miami Printer Friendly Version
07/18/14
Summary ToggleViewRay to Showcase its MRIdian System in Booth 639 at 2014 Medical Physics Meeting Printer Friendly Version
02/05/14
Summary ToggleViewRay™ Announces World’s First Patients Treated Using MRI-Guided Radiation Therapy Printer Friendly Version
12/17/13
Summary ToggleViewRay™ Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System Printer Friendly Version
05/30/13
Summary ToggleViewRay’s Chief Medical Officer Honored by American Society for Radiation Oncology (ASTRO) Printer Friendly Version
02/04/13
Summary ToggleViewRay Appoints Chris A. Raanes President and CEO Printer Friendly Version
07/11/12
Summary ToggleSiteman Cancer Center at Barnes-Jewish and Washington University Begins Imaging with ViewRay System Printer Friendly Version
05/30/12
Summary ToggleViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System Printer Friendly Version
03/20/12
Summary ToggleViewRay Names Michael Brandt Senior Vice President of Sales Printer Friendly Version
03/13/12
Summary ToggleViewRay Closes Round of Series C Financing Printer Friendly Version
09/29/11
Summary ToggleViewRay Demonstrates Potential Therapy Applications for MRI-Guided Radiation at ASTRO 2011 Printer Friendly Version
09/27/11
Summary ToggleUCLA Health System – Jonsson Comprehensive Cancer Center to Acquire ViewRay System Printer Friendly Version
05/24/11
Summary ToggleViewRay Earns TiE50 Award Printer Friendly Version
05/18/11
Summary ToggleLandmark Patents Issued for ViewRay Technology Printer Friendly Version
03/09/11
Summary ToggleUniversity of Wisconsin Carbone Cancer Center to Acquire ViewRay Radiation Therapy System Printer Friendly Version
02/23/11
Summary ToggleViewRay Receives FDA 510(k) Marketing Clearance for Treatment Planning and Delivery Software Printer Friendly Version
10/29/10
Summary ToggleViewRay Introduces Vision for MRI-Guided Radiotherapy at ASTRO 2010 Printer Friendly Version
08/25/10
Summary ToggleViewRay Secures Series C Financing Printer Friendly Version
08/03/10
Summary ToggleSiteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay System Printer Friendly Version
02/16/10
Summary ToggleViewRay Wins NorTech Innovation Award Printer Friendly Version
04/21/09
Summary ToggleViewRay Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG Printer Friendly Version
01/21/08
Summary ToggleViewRay Incorporated Raises $25 Million in Series B Financing Printer Friendly Version
ViewRay

ViewRay Headquarters

2 Thermo Fisher Way
Oakwood Village, Ohio 44146 +1 (440) 703-3210
info@viewray.com